Drawing for SEMNUR PHARMACEUTICALS

USPTO serial 88503719

SEMNUR PHARMACEUTICALS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MCDORMAN, ROGER THOMAS
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SEMNUR PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Paul Oleksiuk

John Paul Oleksiuk Cooley LLP1299 Pennsylvania Avenue, NW, Suite 700Washington, DC 20004-2400UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pain relief medication; preparations for the relief of pain; injectable pharmaceutical gels for treatment of back pain, including lumbosacral radicular pain and sciatica; dexamethasone sodium phosphate for medical use for use in the treatment of pain; dexamethasone sodium phosphate gel for medical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 21, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 20, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 25, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 24, 2022EX5GSOU EXTENSION 5 GRANTED—
May 24, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 20, 2022EXT5SOU EXTENSION 5 FILED—
May 20, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 21, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 17, 2021EX4GSOU EXTENSION 4 GRANTED—
Dec 17, 2021EXT4SOU EXTENSION 4 FILED—
Dec 17, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 22, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 18, 2021EX3GSOU EXTENSION 3 GRANTED—
Jun 18, 2021EXT3SOU EXTENSION 3 FILED—
Jun 18, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 18, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 16, 2020EX2GSOU EXTENSION 2 GRANTED—
Dec 16, 2020EXT2SOU EXTENSION 2 FILED—
Dec 16, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 15, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 13, 2020EX1GSOU EXTENSION 1 GRANTED—
Jul 13, 2020EXT1SOU EXTENSION 1 FILED—
Jul 13, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 14, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 19, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 30, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 10, 2019ALIEASSIGNED TO LIE—
Oct 7, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 30, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 27, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 27, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 26, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 26, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 26, 2019GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 26, 2019GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 26, 2019CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 24, 2019DOCKASSIGNED TO EXAMINER—
Jul 16, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 11, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance